Evolving pharmacovigilance requirements with novel vaccines and vaccine components | BMJ Global Health

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Archive

Authors

About

Blog

Supplements
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

XML

Analysis

Evolving pharmacovigilance requirements with novel vaccines and vaccine components

Online download statistics by month:

Online download statistics by month: May 2021 to March 2024

	Abstract	Full	Pdf
May 2021	119	118	68
Jun 2021	106	100	50
Jul 2021	139	128	46
Aug 2021	56	53	20
Sep 2021	88	74	35
Oct 2021	76	71	41
Nov 2021	83	71	31
Dec 2021	30	30	10
Jan 2022	41	40	12
Feb 2022	59	48	18
Mar 2022	112	103	36
Apr 2022	105	99	29
May 2022	96	71	35
Jun 2022	59	56	20
Jul 2022	43	42	13
Aug 2022	48	44	22
Sep 2022	52	48	21
Oct 2022	83	65	37
Nov 2022	46	40	16
Dec 2022	41	33	21
Jan 2023	47	87	20
Feb 2023	74	69	27
Mar 2023	37	39	12
Apr 2023	42	31	27
May 2023	71	65	28
Jun 2023	38	34	20
Jul 2023	42	29	25
Aug 2023	31	22	13
Sep 2023	46	39	15
Oct 2023	43	38	22
Nov 2023	47	40	22
Dec 2023	49	43	16
Jan 2024	25	26	15
Feb 2024	77	44	14
Mar 2024	104	96	26
Total	2255	2036	883